Literature DB >> 10398878

Embryonic lymphangiogenesis.

J Wilting1, H Neeff, B Christ.   

Abstract

About 8-9 decades ago the development of embryonic lymphatics was studied intensively. Since then our knowledge has not considerably increased in this field, and it is still unknown whether lymphatics are derived by sprouting from veins, de novo from lymphangioblasts, or by both mechanisms. However, very recent studies have shown that the vascular endothelial growth factor-C (VEGF-C) is a highly specific lymphangiogenic growth factor. This raises new questions and perspectives. Here we will review the literature on embryonic lymphangiogenesis and lymphangiogenic growth factors. We also present a description of the pattern of the lymphatics of avian embryos with emphasis on lymph hearts. The avian embryo is highly suited for studies on lymphatics, because these can be demonstrated by injection methods, serial sectioning and in situ hybridization with VEGF-receptor-2 and -3 probes. The greatest advantage resides in the fact that the lymphatics of the chorioallantoic membrane are easily accessible for experimental studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398878     DOI: 10.1007/s004410051328

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  4 in total

1.  Fast optically sectioned fluorescence HiLo endomicroscopy.

Authors:  Tim N Ford; Daryl Lim; Jerome Mertz
Journal:  J Biomed Opt       Date:  2012-02       Impact factor: 3.170

Review 2.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

3.  Establishment of lymphangioma model and a study on the promoting effect of murine melanoma cell B16-F1 on the lymphangiogenesis in vitro.

Authors:  Siyuan Chen; Aijun Chen; Changzheng Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

4.  Dose-dependent response of FGF-2 for lymphangiogenesis.

Authors:  Lynn K Chang; Guillermo Garcia-Cardeña; Filip Farnebo; Michael Fannon; Emy J Chen; Catherine Butterfield; Marsha A Moses; Richard C Mulligan; Judah Folkman; Arja Kaipainen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.